Bora Kwon 권보라

@UKLabour Councillor for College Park and Old Oak ward |
@LBHF Cabinet Member for the Environment, Arts and Culture |
Konglish 🇬🇧🇰🇷💜⁷

[Bora Kwon 권보라 @borakwon]

Promoted by Callum Nimmo on behalf of Hammersmith and Fulham Labour, both at 28 Greyhound Road, London W6 8NX

[H&F Council @LBHF]

We will be marking Remembrance Sunday with services at Shepherds Bush and Fulham War Memorials.

Everyone is invited to join dignitaries from H&F Council and the community as we pay our respects on Sunday 8 November.

More info: https://t.co/lIGCdoyKzI

[Bora Kwon 권보라 @borakwon]

@hyyhddaeng Your Korean doesn't suck and AI autotranslate has no rizz. It's like confusing "it's the sh*t" for "it's sh*t" 😑

[Bora Kwon 권보라 @borakwon]

I was very happy to participate in this clinical trial whilst undergoing breast cancer treatment. I did have to undergo chemotherapy but the data from the study has meant thousands of women have been able to safely skip it and hopefully many thousands more will in the future 💕

[Veracyte, Inc. @Veracyte]

At 47, Bora was balancing an office-based role as a local elected politician when she received a breast cancer diagnosis that came as a complete shock.

She had experienced lumpy breasts for 10 to 15 years, with changes that often became more noticeable during her menstrual cycle. When one lump did not go away, she arranged to have it checked. An ultrasound and biopsy confirmed breast cancer.

“I cried,” she says. “It was a total shock.”

Bora approached the diagnosis in a practical way, drawing on her previous experience as a journalist to research the disease and understand the available information. But the process was still difficult.

Referrals, appointments and decisions about surgery meant that roughly two weeks could pass between each step. She was referred to two surgeons while considering how to move forward with treatment as quickly as possible.

She chose to be open about her diagnosis and found that talking with friends and loved ones was an important source of support. Living alone, she particularly valued having people around her who could help her process what was happening.

After her second surgery, her care team needed to determine whether she required additional chemotherapy. The team told her about the OPTIMA trial, which, according to her team, was investigating whether genomic testing could help guide treatment decisions.

Bora had a positive view of clinical research and had already taken part in other studies. She discussed the trial information with friends who were oncologists and decided to participate.

Her main concern was whether she might get her hopes up, as she expected that chemotherapy would probably be recommended.

“To be honest, I kind of forgot I was involved in it,” she says. Participation involved completing a questionnaire about every three months, focused on lifestyle and how she was feeling.

For Bora, the experience reinforced the value of clear, personalized information.

“Data and information can be empowering when they are explained properly,” she says. “There are different types of breast cancer, treatment options and decisions. When testing is available alongside appropriate medical advice, it can help patients feel more empowered.”

🩷 In honor of #BreastCancerAwarenessMonth, join us in thanking the people, like Bora, who took part in the OPTIMA trial - https://t.co/x4O6U2SyuO

#BreastCancer #CancerClinicalTrials #BreastCancerResearch #BecauseTheySaidYes #ResearchIsTheReason #BreastCancerJourney

[Veracyte, Inc. @Veracyte]

At 47, Bora was balancing an office-based role as a local elected politician when she received a breast cancer diagnosis that came as a complete shock.

She had experienced lumpy breasts for 10 to 15 years, with changes that often became more noticeable during her menstrual cycle. When one lump did not go away, she arranged to have it checked. An ultrasound and biopsy confirmed breast cancer.

“I cried,” she says. “It was a total shock.”

Bora approached the diagnosis in a practical way, drawing on her previous experience as a journalist to research the disease and understand the available information. But the process was still difficult.

Referrals, appointments and decisions about surgery meant that roughly two weeks could pass between each step. She was referred to two surgeons while considering how to move forward with treatment as quickly as possible.

She chose to be open about her diagnosis and found that talking with friends and loved ones was an important source of support. Living alone, she particularly valued having people around her who could help her process what was happening.

After her second surgery, her care team needed to determine whether she required additional chemotherapy. The team told her about the OPTIMA trial, which, according to her team, was investigating whether genomic testing could help guide treatment decisions.

Bora had a positive view of clinical research and had already taken part in other studies. She discussed the trial information with friends who were oncologists and decided to participate.

Her main concern was whether she might get her hopes up, as she expected that chemotherapy would probably be recommended.

“To be honest, I kind of forgot I was involved in it,” she says. Participation involved completing a questionnaire about every three months, focused on lifestyle and how she was feeling.

For Bora, the experience reinforced the value of clear, personalized information.

“Data and information can be empowering when they are explained properly,” she says. “There are different types of breast cancer, treatment options and decisions. When testing is available alongside appropriate medical advice, it can help patients feel more empowered.”

🩷 In honor of #BreastCancerAwarenessMonth, join us in thanking the people, like Bora, who took part in the OPTIMA trial - https://t.co/x4O6U2SyuO

#BreastCancer #CancerClinicalTrials #BreastCancerResearch #BecauseTheySaidYes #ResearchIsTheReason #BreastCancerJourney

[Veracyte, Inc. @Veracyte]

#BreastCancerResearch depends on brave people who say yes to clinical trials. Their courage drives new possibilities, leading to better tests and treatments for the people who come next.

🎀 So, in recognition of #BreastCancerAwarenessMonth, please join us in thanking the people who took part in the OPTIMA trial.

| #BecauseTheySaidYes |

Based on the OPTIMA trial, more than two-thirds of people with clinically high-risk breast cancer, may safely avoid chemotherapy. The OPTIMA trial showed that the Prosigna test can be used to predict chemotherapy benefit for people with HR+ breast cancer.

| The People Who Said Yes |

4,429 people joined OPTIMA across six countries. Because they said “yes” doctors can better support personalized chemotherapy decisions and make sure that the right treatment is given to the right patients.

🩷 Share your thanks here - https://t.co/QZReHENjFW

#BreastCancer #CancerClinicalTrials #ResearchIsTheReason

[Dolly Parton @DollyParton]

Maybe my next #Jolene collab will be with @BTS_twt? What do y'all think? #GRAMMYs

[Bora Kwon 권보라 @borakwon]

@CCjo7949 One-year post-chemo and radiotherapy Army here - sending you all the borahae good wishes for your treatment 💜

[H&F Council @LBHF]

We marked Armed Forces Day on Saturday with a special event in St Paul's Gardens, Hammersmith.

British veterans of the Korean War shared their stories and experiences, commemorating the Korean Armistice, along with a range of Korean cultural performances.

[Bora Kwon 권보라 @borakwon]

@BorahaeArts 🏃‍♀️

[Bora Kwon 권보라 @borakwon]

@BorahaeArts Can you use the Elizabeth line instead? Air-con carriages 🌬

[Bora Kwon 권보라 @borakwon]

@OldLondonW14 https://t.co/kzT8PmldSy

[H&F Council @LBHF]

The Met Office has issued a red weather warning for extreme heat in London, for Wednesday and Thursday.

We have advice on our website about staying safe, and places to cool down in H&F: https://t.co/EvUHVV2AmC

[Bora Kwon 권보라 @borakwon]

@isa_ipmp As a frequent London-Korea flyer, a gel cushion seat pad helps so much in economy seats! Save travels 💜

[H&F Council @LBHF]

H&F Council has been awarded highest rating for supporting children with special educational needs and disabilities.

Our Local Area Partnership was praised for its work by Ofsted and the Care Quality Commission (CQC).

More: https://t.co/Abzi6RRAjO

[H&F Council @LBHF]

ELECTION RESULT - COLLEGE PARK AND OLD OAK WARD
The three Councillors elected are:

Wesley Harcourt (LAB)
Alexandra Sanderson (LAB)
Bora Kwon (LAB)

Full H&F election results update here: https://t.co/4tMEBNcmWk

[Bora Kwon 권보라 @borakwon]

I wish @cllr_hewitson all the luck with her ongoing battle against cancer

[Manchester Labour 🐝 @McrLabour]

Attacking a hard working councillor for battling cancer is a new low.

@cllr_hewitson is one of the hardest working local councillors, coming to meetings and helping her residents *during* her cancer treatment.

Appalling.

We’re with you Tina 🌹

https://t.co/XXpTqOEfyu

[Bora Kwon 권보라 @borakwon]

@NS0793 https://t.co/uWcZHnfxP6

Junction of Wood Lane and Ariel Way!

[Bora Kwon 권보라 @borakwon]

I spent 6 months under the care of the chemo day unit team at Charing Cross and the team there are phenomenal. Everyone from the admin and support members through to the medical staff are wonderful at what they do. Please share and donate @ImperialCharity #Cancer #chemo

[Imperial Health Charity @ImperialCharity]

Today, we’re launching our Winter Appeal supporting the chemotherapy day unit at Charing Cross Hospital.

Please help us raise funds to make the unit a brighter, more welcoming space for patients receiving cancer treatment.

Show your support: https://t.co/YQd5XrIcrc

[Hammersmith and Fulham Labour @HFLabour]

We oppose the closure of the front counter at Hammersmith Police Station and are investing record amounts of funding to tackle crime and ASB.

Residents won't be fooled by the Conservative cllrs who've voted against every crime-fighting measure that is making our borough safer.